What is NDC 55111-311?

55111-311 is the product NDC for Nizatidine, Nizatidine 300 mg/1 capsule, listed with the FDA by Dr Reddy's Laboratories Limited. It has 5 package NDCs, shown above in 10- and 11-digit form.

Dr Reddy's Laboratories Limited, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Nizatidine?

5 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Nizatidine NDC 55111-311 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)55111-311Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55111-0311Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
55111-311-01	5511103110155111031101	100 CAPSULE in 1 BOTTLE (55111-311-01)Marketed from Sep 15, 2005
55111-311-05	5511103110555111031105	500 CAPSULE in 1 BOTTLE (55111-311-05)Marketed from Sep 15, 2005
55111-311-30	5511103113055111031130	30 CAPSULE in 1 BOTTLE (55111-311-30)Marketed from Sep 15, 2005
55111-311-60	5511103116055111031160	60 CAPSULE in 1 BOTTLE (55111-311-60)Marketed from Sep 15, 2005
55111-311-78	5511103117855111031178	10 BLISTER PACK in 1 CARTON (55111-311-78) / 10 CAPSULE in 1 BLISTER PACK (55111-311-79)Marketed from Sep 15, 2005

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nizatidine
Generic name (nonproprietary): nizatidine
Active ingredients: Nizatidine — 300 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Dr Reddy's Laboratories LimitedNDC labeler code 55111
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077314
Marketing start: Sep 15, 2005
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 55111-311_254e5866-1ba8-8d97-bc03-19916119ff87SPL ID 254e5866-1ba8-8d97-bc03-19916119ff87SPL set ID faaa7cc4-fda9-d5b8-de2a-71c8744ccb76RxCUI 198041, 312025UNII P41PML4GHR
Pharmacologic class: Histamine-2 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455111031101 followed by a unit qualifier and the quantity

Package 55111-0311-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 6, 2018.

Indications (excerpt from the label)

INDICATIONS AND USAGE Nizatidine capsules are indicated for up to 8 weeks for the treatment of active duodenal ulcer. In most patients, the ulcer will heal within 4 weeks. Nizatidine capsules are indicated for maintenance therapy for duodenal ulcer patients at a reduced dosage of 150 mg h.s. after healing of an active duodenal ulcer. The consequences of continuous therapy with nizatidine for longer than 1 year are not known. Nizatidine capsules are indicated for up to 12 weeks for the treatment of endoscopically diagnosed esophagitis, including erosive and ulcerative esophagitis, and associated heartburn due to GERD. Nizatidine capsules are indicated for up to 8 weeks for the treatment of ac…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55111-311

What is NDC 55111-311?: 55111-311 is the product NDC for Nizatidine, Nizatidine 300 mg/1 capsule, listed with the FDA by Dr Reddy's Laboratories Limited. It has 5 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Nizatidine.
What is the active ingredient?: Nizatidine.
Who is the labeler?: Dr Reddy's Laboratories Limited, NDC labeler code 55111. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Nizatidine?: 5 other product NDCs are listed under this name. See all Nizatidine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Nizatidine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Nizatidine	Nizatidine 150 mg/1	CapsuleOral	Epic Pharma, LLC	42806-299	42806-0299-3042806-0299-60
Nizatidine	Nizatidine 300 mg/1	CapsuleOral	Epic Pharma, LLC	42806-300	42806-0300-3042806-0300-60
Nizatidine	Nizatidine 15 mg/mL	SolutionOral	Amneal Pharmaceuticals LLC	60846-301	60846-0301-15
Nizatidine	Nizatidine 150 mg/1	CapsuleOral	Dr Reddy's Laboratories Limited	55111-310	55111-0310-0155111-0310-0555111-0310-30+2 more
Nizatidine	Nizatidine 150 mg/1	CapsuleOral	Actavis Pharma, Inc.	0591-3137	00591-3137-60

Other NDCs under ANDA 077314

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077314
Product	Strength	Form · route	Labeler	Product NDC
Nizatidine	Nizatidine 150 mg/1	CapsuleOral	Dr Reddy's Laboratories Limited	55111-310